...
首页> 外文期刊>The Internet Journal of Urology >Detection Of Escherichia Coli DNA From Interstitial Cystitis Bladder Biopsies Provides Little Evidence Of A Causal Microbe
【24h】

Detection Of Escherichia Coli DNA From Interstitial Cystitis Bladder Biopsies Provides Little Evidence Of A Causal Microbe

机译:从间质性膀胱炎活检组织中检测大肠埃希氏大肠杆菌DNA很少提供因果微生物的证据。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The aetiology of interstitial cystitis in patients remains unknown and despite many investigations no single micro-organism has been implicated. We have studied the possible role of bacteria in interstitial cystitis by investigating PCR amplified DNA sequences from 33 individually well-documented interstitial cystitis patients. The frozen or archived bladder biopsy specimens have been examined for the presence of bacterial DNA by the amplification of 16S rRNA and subsequent RFLP of cloned DNA fragments. Bacterial DNA was detected from 21/33 (64%) of frozen or archived bladder biopsy samples. RFLP analysis of cloned DNA strongly resembled the fragment profile of Escherichia coli DNA in 10/33 (30%) of the IC biopsy samples overall or 10/21 (48%) of the samples that had yielded any DNA. Bacterial DNA was however identified in 4/5 (80%) of samples from non-interstitial cystitis bladder biopsy patients. The significance of the presence of E.coli DNA in 48% of interstitial cystitis bladder biopsies is clearly tempered by the finding of a high proportion of E.coli DNA in non-interstitial cystitis patients. The issues of appropriate control groups and adequate methods to ensure authentic DNA are discussed. Introduction The aetiology of interstitial cystitis (IC) in patients continues to elude us and despite intensive research, the possible causative agent of the disease and its ideal treatment remains unknown. Acute onset with exacerbations and remissions, a previous history of urinary tract infections, virtual confinement of the disease to female patients in which the short urethra allows easy access to bacteria, all strongly suggest an infective aetiology [1]. However, over the past three decades, numerous studies using traditional isolation techniques have failed to convincingly identify any bacterial, viral or protozoal agent(s) responsible for the disease. The requirement to recover organisms from patients by growing them on artificial media or identify extremely fastidious or ‘non-culturable’ organisms has limited progress in the investigation of IC. Advances in molecular-based diagnosis, however, have allowed a new strategic approach by which workers use nucleic acid-based methodology to exclude the presence of specific exogenous microbes as the aetiological cause. PCR amplification of bacterial DNA for the potential identification of specific causal pathogens in frozen IC biopsy specimens has been investigated previously. Using this approach, Hampson et al [2] excluded the specific presence of mycobacterial DNA in IC biopsy specimens and Hukkanen et al [3] excluded the presence in IC specimens of the adenovirus or BK virus genome. Agarwal and Dixon [4,5] specifically excluded the bacterial pathogens Gardnerella vaginalis and Helicobacter pylori respectively and various other pathogens have also been excluded [6]. Escherichia coli remains a possible candidate in the pathogenesis of IC especially as data from Anderson et al [7] suggests that E coli in mice is internalized into bladder epithelial cells and persists for months. In some patients, onset of IC can correlate with evidence of UTI or urinary inflammation originating from episodes of E.coli infection. (J.W. Warren - personal communication). Investigations into the aetiology of IC using patient groups has remained limited, often due to insufficient frozen biopsy specimens and to date, studies have been small and conclusions difficult to make. In the present study, we are attempting to detect DNA from any bacteria present not only from frozen biopsies but a larger number of material preserved in paraffin wax. Materials and Methods Thirty-three bladder biopsy specimens (including 29 paraffin-embedded and 4 fresh frozen specimens) were collected from patients with a clinical diagnosis of IC fulfilling (National Institute of Diabetes and Digestive and Kidney diseases - NIDDK) criteria [8] with some modifications (criteria based on cystometrogram were not strictly adhered to,
机译:患者间质性膀胱炎的病因仍然未知,尽管进行了许多研究,但没有涉及任何微生物。我们已经通过调查33个单独有据可查的间质性膀胱炎患者的PCR扩增DNA序列,研究了细菌在间质性膀胱炎中的可能作用。通过扩增16S rRNA和随后的克隆DNA片段RFLP,检查了冷冻或存档的膀胱活检标本中是否存在细菌DNA。从21/33(64%)的冷冻或存档膀胱活检样品中检测到细菌DNA。对克隆的DNA进行RFLP分析与IC活检样本总数的10/33(30%)或产生任何DNA的样本的10/21(48%)的大肠杆菌DNA片段特征非常相似。然而,在非间质性膀胱炎膀胱活检患者的样本中,有4/5(80%)的细菌DNA被鉴定。通过在非间质性膀胱炎患者中发现高比例的大肠杆菌DNA,明显消除了48%的间质性膀胱炎膀胱活检组织中存在大肠杆菌DNA的重要性。讨论了适当对照组和确保真实DNA的适当方法的问题。引言患者间质性膀胱炎(IC)的病因仍在继续,尽管进行了深入研究,但该病的可能病因及其理想的治疗方法仍然未知。急性发作加重和缓解,尿路感染的既往史,该病实际上局限于女性患者,其中短尿道使得细菌容易进入,所有这些都强烈暗示了感染性病因[1]。然而,在过去的三十年中,使用传统隔离技术进行的大量研究未能令人信服地鉴定出引起该疾病的任何细菌,病毒或原生动物因子。通过在人工培养基上生长患者或鉴定极其挑剔或“不可培养”的生物来从患者体内恢复生物的要求限制了IC研究的进展。然而,基于分子的诊断技术的进步已经允许一种新的战略方法,该方法使工人可以使用基于核酸的方法来排除特定外源微生物作为病因的原因。先前已经研究了细菌DNA的PCR扩增,以潜在鉴定冷冻IC活检标本中的特定致病菌。使用这种方法,Hampson等[2]排除了IC活检标本中分枝杆菌DNA的特定存在,而Hukkanen等[3]排除了IC样本中存在腺病毒或BK病毒基因组的分枝。 Agarwal和Dixon [4,5]分别专门排除了细菌病原体阴道加德纳菌和幽门螺杆菌,还排除了其他各种病原体[6]。大肠埃希氏菌仍可能是IC发病机制中的候选者,尤其是Anderson等人的数据[7]指出,小鼠体内的大肠埃希菌已被内化到膀胱上皮细胞中并持续了数月之久。在某些患者中,IC发作可能与源自大肠杆菌感染发作的尿路感染或尿道炎症的证据相关。 (J.W. Warren-个人通讯)。使用患者组对IC的病因学的研究仍然很有限,这通常是由于冷冻活检标本不足所致,迄今为止,研究规模很小,难以得出结论。在本研究中,我们试图检测不仅存在于冷冻活检组织中,而且存在于石蜡中保存的大量物质中的任何细菌中的DNA。材料和方法从IC诊断符合IC(美国糖尿病与消化及肾脏疾病研究所-NIDDK)标准[8]的患者中收集33份膀胱活检标本(包括29份石蜡包埋和4份新鲜冷冻标本)[8]。某些修改(严格遵守基于膀胱造影图的标准,

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号